Clinical trial
Cyclophosphamide and Prednisone Followed by Methotrexate To Treat Vasculitides
NCT00001473 · National Institute of Allergy and Infectious Diseases (NIAID), NIH · Completed
Key facts
| NCT number | NCT00001473 |
|---|---|
| Title | Cyclophosphamide and Prednisone Followed by Methotrexate To Treat Vasculitides |
| Official title | A Staged Therapeutic Approach Using Cyclophosphamide and Methotrexate in the Treatment of Wegener's Granulomatosis and Related Vasculitides |
| Lead sponsor | National Institute of Allergy and Infectious Diseases (NIAID), NIH |
| Status | Completed |
| Study type | Observational |
| Conditions | Vasculitis, Wegener's Granulomatosis |
| Enrollment | 100 |
| Start date | Mar 1, 1995 |
| Completion | Mar 1, 2004 |
| First posted | Nov 4, 1999 |
| Last update posted | Mar 4, 2008 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: